Diagnostic accuracy and added value of blood-based protein biomarkers for pancreatic cancer: a meta-analysis of aggregate and individual participant data
Lenka N.C. Boyd(Amsterdam University Medical Centers), Geert Kazemier(European Organisation for Research and Treatment of Cancer), Ralph de Vries(Vrije Universiteit Amsterdam), Tessa Y. S. Le Large(Amsterdam University Medical Centers), Hanneke W.M. van Laarhoven(Dutch Cancer Society), Mahsoem Ali(Amsterdam Neuroscience), Elisa Giovannetti(University of Pisa), Giorgio Treglia(Ente Ospedaliero Cantonale), Mariska Leeflang(Academic Medical Center), Marc G. Besselink(Amsterdam Neuroscience)
Cited by 76
Related Papers
Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection
|Cochrane Database of Systematic Reviews|2020|1.3k
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
|Journal of Clinical Oncology|2020|1.1k
Endoscopic Transgastric vs Surgical Necrosectomy for Infected Necrotizing Pancreatitis
|JAMA|2012|735
Endoscopic or surgical step-up approach for infected necrotising pancreatitis: a multicentre randomised trial
|The Lancet|2017|715
United European Gastroenterology evidence‐based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU)
|United European Gastroenterology Journal|2017|698